• August’s top news stories

    Gradalis started a Phase lll clinical trial of Vigil in combination with irinotecan and temozolomide for the treatment of patients with Ewing’s sarcoma, and Impel NeuroPharma dosed the first subject...

  • July’s top news stories

    The Kyoto University’s Centre for iPS Cell Research and Application (CiRA) in Japan is to start two clinical trials that will evaluate human induced pluripotent stem cells (iPS) to treat...

  • May’s top news stories

    Abivax unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human immunodeficiency virus (HIV), as well as a method to treat inflammatory...

  • Pharma Technology Focus – Issue 45

    In this issue: Israel’s pharma market, what Brexit would mean for clinical research in the UK, developments in obstetrics, the trouble with inhalable insulin, the FDA’s new support for innovation...

  • Pharma Technology Focus – Issue 44

    In this issue: Clinical trials in Russia, how understanding the microbiome could help with drug delivery, making the most of data analytics, the potential of wearable trackers in clinical trial...

Go Top